RTX Corp (RTX) stock
Close on Oct 30, 2026Market cap $269.28BP/E 35.2Yield 1.34%
Earnings
RTX's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of RTX's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Jan 26, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 20, 2026before the open | $25.00B | +11.1% | $1.89 | $2.26 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 23, 2026before the open | $24.70B | +14.4% | $1.57 | $1.89 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 21, 2026before the open | $22.10B | +8.9% | $1.51 | $1.78 | Release |
| Q4 FY2025ended Dec 31, 2025 | Jan 27, 2026before the open | $24.20B | +12.0% | $1.19 | $1.55 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 21, 2025before the open | $22.50B | +11.9% | $1.41 | $1.70 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 22, 2025before the open | $21.60B | +9.6% | $1.22 | $1.56 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 22, 2025before the open | $20.30B | +5.2% | $1.14 | $1.47 | Release |
| Q4 FY2024ended Dec 31, 2024 | Jan 28, 2025before the open | $21.60B | +8.5% | $1.10 | $1.54 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 22, 2024before the open | $20.10B | +48.9% | $1.09 | $1.45 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 25, 2024before the open | $19.70B | +7.7% | $0.08 | $1.41 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 23, 2024before the open | $19.30B | +12.2% | $1.28 | $1.34 | Release |
| Q4 FY2023ended Dec 31, 2023 | Jan 23, 2024before the open | $19.90B | +9.9% | $1.05 | $1.29 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 24, 2023before the open | $13.50B | -20.6% | -$0.68 | $1.25 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 25, 2023before the open | $18.30B | +12.3% | $0.90 | $1.29 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 25, 2023before the open | $17.20B | +9.6% | $0.97 | $1.22 | Release |
| Q4 FY2022ended Dec 31, 2022 | Jan 24, 2023before the open | $18.10B | +6.5% | $0.96 | $1.27 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 25, 2022before the open | $17.00B | +4.9% | $0.94 | $1.21 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 26, 2022before the open | $16.30B | – | $0.88 | $1.16 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 26, 2022before the open | $15.70B | – | $0.74 | $1.15 | Release |
| Q4 FY2021ended Dec 31, 2021 | Jan 25, 2022before the open | $17.00B | – | $0.46 | $1.08 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 26, 2021before the open | $16.20B | – | $0.93 | $1.26 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 27, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 27, 2021before the open | – | – | – | – | Release |
| Q4 FY2020ended Dec 31, 2020 | Jan 26, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 27, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
RTX's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Adjusted salesnon-GAAP | FY2026 | $95.00B – $96.00B | $92.50B – $93.50B | Raised | Jul 23, 2026 |
| Adjusted sales*non-GAAP | FY2026 | $97.00B – $97.50B | – | New | Oct 20, 2026 |
| Organic sales growthnon-GAAP | FY2026 | +8% – +9% | +5% – +6% | Raised | Jul 23, 2026 |
| Organic sales growth*non-GAAP | FY2026 | +10% – +11% | – | New | Oct 20, 2026 |
| Adjusted EPSnon-GAAP | FY2026 | $7.10 – $7.25 | $6.70 – $6.90 | Raised | Jul 23, 2026 |
| Adjusted EPS*non-GAAP | FY2026 | $7.65 – $7.75 | – | New | Oct 20, 2026 |
| Free cash flownon-GAAP | FY2026 | $8.50B – $8.75B | $8.25B – $8.75B | Raised | Jul 23, 2026 |
| Free cash flow*non-GAAP | FY2026 | $9.00B – $9.20B | – | New | Oct 20, 2026 |
Guidance vs results
The last range RTX gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Adjusted EPS* | $6.10 – $6.20 | $6.28Σ4Q | Above range |
| FY2025 | Revenue | $86.50B – $87.00B | $88.60BΣ4Q | Above range |
Guidance history
Every forecast RTX put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 20, 2026 | Adjusted EPS* | FY2026 | $7.65 – $7.75 | New |
| Oct 20, 2026 | Free cash flow* | FY2026 | $9.00B – $9.20B | New |
| Oct 20, 2026 | Organic sales growth* | FY2026 | +10% – +11% | New |
| Oct 20, 2026 | Adjusted sales* | FY2026 | $97.00B – $97.50B | New |
| Jul 23, 2026 | Adjusted EPS | FY2026 | $7.10 – $7.25 | Raised |
| Jul 23, 2026 | Free cash flow | FY2026 | $8.50B – $8.75B | Raised |
| Jul 23, 2026 | Adjusted sales | FY2026 | $95.00B – $96.00B | Raised |
| Jul 23, 2026 | Organic sales growth | FY2026 | +8% – +9% | Raised |
| Apr 21, 2026 | Adjusted EPS* | FY2026 | $6.70 – $6.90 | Raised |
| Apr 21, 2026 | free cash flow* | FY2026 | $8.25B – $8.75B | Reaffirmed |
| Apr 21, 2026 | Adjusted sales* | FY2026 | $92.50B – $93.50B | Raised |
| Apr 21, 2026 | Organic sales growth* | FY2026 | +5% – +6% | Reaffirmed |
| Jan 27, 2026 | Adjusted EPS* | FY2026 | $6.60 – $6.80 | New |
| Jan 27, 2026 | Free cash flow* | FY2026 | $8.25B – $8.75B | New |
| Jan 27, 2026 | Adjusted sales* | FY2026 | $92.00B – $93.00B | New |
| Jan 27, 2026 | Organic sales growth* | FY2026 | +5% – +6% | New |
| Oct 21, 2025 | Adjusted EPS* | FY2025 | $6.10 – $6.20 | Raised |
| Oct 21, 2025 | free cash flow* | FY2025 | $7.00B – $7.50B | Reaffirmed |
| Oct 21, 2025 | Organic sales growth* | FY2025 | +8% – +9% | New |
| Oct 21, 2025 | Adjusted sales* | FY2025 | $86.50B – $87.00B | Raised |
| Jul 22, 2025 | Adjusted EPS* | FY2025 | $5.80 – $5.95 | New |
| Jul 22, 2025 | free cash flow* | FY2025 | $7.00B – $7.50B | New |
| Jul 22, 2025 | Adjusted sales* | FY2025 | $84.75B – $85.50B | New |
| Jul 22, 2025 | Organic sales growth* | FY2025 | +6% – +7% | New |
| Apr 22, 2025 | Adjusted EPS* | FY2025 | $6.00 – $6.15 | Reaffirmed |
| Apr 22, 2025 | Free cash flow* | FY2025 | $7.00B – $7.50B | Reaffirmed |
| Apr 22, 2025 | Adjusted sales* | FY2025 | $83.00B – $84.00B | Reaffirmed |
| Apr 22, 2025 | organic growth* | FY2025 | +4% – +6% | Reaffirmed |
| Jan 28, 2025 | Adjusted EPS* | FY2025 | $6.00 – $6.15 | New |
| Jan 28, 2025 | Free cash flow* | FY2025 | $7.00B – $7.50B | New |
| Jan 28, 2025 | Adjusted sales* | FY2025 | $83.00B – $84.00B | New |
| Jan 28, 2025 | organic growth* | FY2025 | +4% – +6% | New |
| Oct 22, 2024 | Adjusted EPS | FY2024 | $5.50 – $5.58 | Raised |
| Oct 22, 2024 | free cash flow | FY2024 | $4.70B | Reaffirmed |
| Oct 22, 2024 | Adjusted sales | FY2024 | $79.25B – $79.75B | Raised |
| Jul 25, 2024 | Adjusted EPS* | FY2024 | $5.35 – $5.45 | Raised |
| Jul 25, 2024 | Free cash flow* | FY2024 | $4.70B | Lowered |
| Jul 25, 2024 | Adjusted sales* | FY2024 | $78.75B – $79.50B | New |
| Apr 23, 2024 | Adjusted EPS* | FY2024 | $5.25 – $5.40 | Reaffirmed |
| Apr 23, 2024 | Free cash flow* | FY2024 | $5.70B | Reaffirmed |
| Apr 23, 2024 | Sales | FY2024 | $78.00B – $79.00B | Reaffirmed |
| Jan 23, 2024 | Adjusted EPS | FY2024 | $5.25 – $5.40 | New |
| Jan 23, 2024 | Free cash flow | FY2024 | $5.70B | New |
| Jan 23, 2024 | Sales | FY2024 | $78.00B – $79.00B | New |
| Oct 24, 2023 | Adjusted EPS* | FY2023 | $4.98 – $5.02 | Narrowed |
| Oct 24, 2023 | Free cash flow* | FY2023 | $4.80B | Raised |
| Oct 24, 2023 | Share repurchase spending | FY2023 | $12.80B | Raised |
| Oct 24, 2023 | Reported sales | FY2023 | $68.50B | Lowered |
| Oct 24, 2023 | Adjusted sales* | FY2023 | $74.00B | New |
| Jul 25, 2023 | Adjusted EPS* | FY2023 | $4.95 – $5.05 | Raised |
| Jul 25, 2023 | Free cash flow* | FY2023 | $4.30B | Lowered |
| Jul 25, 2023 | Sales | FY2023 | $73.00B – $74.00B | New |
| Apr 25, 2023 | Adjusted EPS | FY2023 | $4.90 – $5.05 | Reaffirmed |
| Apr 25, 2023 | Free cash flow | FY2023 | $4.80B | Reaffirmed |
| Apr 25, 2023 | Share repurchase | FY2023 | $3.00B | Reaffirmed |
| Apr 25, 2023 | Sales | FY2023 | $72.00B – $73.00B | Reaffirmed |
| Jan 24, 2023 | Adjusted EPS | FY2023 | $4.90 – $5.05 | New |
| Jan 24, 2023 | Free cash flow | FY2023 | $4.80B | New |
| Jan 24, 2023 | Share repurchase | FY2023 | $3.00B | New |
| Jan 24, 2023 | Sales | FY2023 | $72.00B – $73.00B | New |
| Oct 25, 2022 | Adjusted EPS | FY2022 | $4.70 – $4.80 | Raised |
| Oct 25, 2022 | free cash flow | FY2022 | $4.00B | Lowered |
| Oct 25, 2022 | Sales | FY2022 | $67.00B – $67.30B | Lowered |
| Jul 26, 2022 | adjusted EPS | FY2022 | $4.60 – $4.80 | Reaffirmed |
| Jul 26, 2022 | free cash flow | FY2022 | $6.00B | Reaffirmed |
| Jul 26, 2022 | share repurchase | FY2022 | $2.50B | New |
| Jul 26, 2022 | sales | FY2022 | $67.75B – $68.75B | Lowered |
| Apr 26, 2022 | adjusted EPS | FY2022 | $4.60 – $4.80 | Reaffirmed |
| Apr 26, 2022 | free cash flow | FY2022 | $6.00B | Reaffirmed |
| Apr 26, 2022 | Sales | FY2022 | $67.75B – $68.75B | New |
| Jan 25, 2022 | Adjusted EPS | FY2022 | $4.60 – $4.80 | New |
| Jan 25, 2022 | Free cash flow | FY2022 | $6.00B | New |
| Jan 25, 2022 | Sales | FY2022 | $68.50B – $69.50B | New |
| Oct 26, 2021 | Adjusted EPS | FY2021 | $4.10 – $4.20 | New |
| Oct 26, 2021 | Free cash flow | FY2021 | $5.00B | New |
| Oct 26, 2021 | Sales | FY2021 | $64.50B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases RTX filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- News
- News
- News
- News
- Results
- Results